Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management.

Holt RI, Peveler RC.

Clin Endocrinol (Oxf). 2011 Feb;74(2):141-7. doi: 10.1111/j.1365-2265.2010.03814.x. Review.

PMID:
20455888
2.

Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.

Haddad PM, Wieck A.

Drugs. 2004;64(20):2291-314. Review.

PMID:
15456328
3.

Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.

O'Keane V.

J Psychopharmacol. 2008 Mar;22(2 Suppl):70-5. doi: 10.1177/0269881107088439. Review.

PMID:
18477623
4.

The impact of hyperprolactinaemia on sexual function in patients with psychosis.

Smith SM.

J Psychopharmacol. 2008 Mar;22(2 Suppl):63-9. doi: 10.1177/0269881107088438. Review.

PMID:
18477622
5.

Hyperprolactinaemia and antipsychotic therapy in schizophrenia.

Hummer M, Huber J.

Curr Med Res Opin. 2004;20(2):189-97. Review.

PMID:
15006013
6.

[Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy].

Riecher-Rössler A, Schmid C, Bleuer S, Birkhäuser M.

Neuropsychiatr. 2009;23(2):71-83. German.

PMID:
19573500
7.

Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.

Holt RI.

J Psychopharmacol. 2008 Mar;22(2 Suppl):28-37. doi: 10.1177/0269881107087951. Review.

PMID:
18477618
8.

[Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].

Besnard I, Auclair V, Callery G, Gabriel-Bordenave C, Roberge C.

Encephale. 2014 Feb;40(1):86-94. doi: 10.1016/j.encep.2012.03.002. Epub 2013 Aug 5. Review. French.

PMID:
23928066
9.

Antipsychotic-induced hyperprolactinaemia.

Inder WJ, Castle D.

Aust N Z J Psychiatry. 2011 Oct;45(10):830-7. doi: 10.3109/00048674.2011.589044. Epub 2011 Jun 30. Review.

PMID:
21714721
10.

A review of the association between antipsychotic use and hyperprolactinaemia.

Bushe C, Shaw M, Peveler RC.

J Psychopharmacol. 2008 Mar;22(2 Suppl):46-55. doi: 10.1177/0269881107088435. Review.

PMID:
18477620
11.

Prolactin, hyperprolactinaemia and antipsychotic treatment: a review and lessons for treatment of early psychosis.

Cookson J, Hodgson R, Wildgust HJ.

J Psychopharmacol. 2012 May;26(5 Suppl):42-51. doi: 10.1177/0269881112442016. Epub 2012 Apr 2. Review.

PMID:
22472310
12.

A review of hyperprolactinaemia and severe mental illness: are there implications for clinical biochemistry?

Bushe CJ, Bradley A, Pendlebury J.

Ann Clin Biochem. 2010 Jul;47(Pt 4):292-300. doi: 10.1258/acb.2010.010025. Review.

PMID:
20592331
13.
14.

[Impact of neuroleptic-induced hyperprolactinemia on sexual dysfunction in male schizophrenic patients].

Konarzewska B, Szulc A, Popławska R, Galińska B, Juchnowicz D.

Psychiatr Pol. 2008 Jan-Feb;42(1):87-95. Review. Polish.

PMID:
18567406
15.

Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Haddad PM, Sharma SG.

CNS Drugs. 2007;21(11):911-36. Review.

PMID:
17927296
16.

The evolution of hyperprolactinaemia as an entity in psychiatric patients.

Kohen D, Wildgust HJ.

J Psychopharmacol. 2008 Mar;22(2 Suppl):6-11. doi: 10.1177/0269216307087147. Review.

PMID:
18477616
17.

Prolactin awareness: an essential consideration for physical health in schizophrenia.

Montejo AL.

Eur Neuropsychopharmacol. 2008 May;18 Suppl 2:S108-14. doi: 10.1016/j.euroneuro.2008.02.004. Review.

PMID:
18346598
18.

Antipsychotic-induced hyperprolactinemia and sexual dysfunction.

Compton MT, Miller AH.

Psychopharmacol Bull. 2002 Winter;36(1):143-64. Review.

PMID:
12397853
19.

Schizophrenia and osteoporosis.

Lean M, De Smedt G.

Int Clin Psychopharmacol. 2004 Jan;19(1):31-5. Review.

PMID:
15101568
20.

Hormonal side effects in women: typical versus atypical antipsychotic treatment.

Dickson RA, Seeman MV, Corenblum B.

J Clin Psychiatry. 2000;61 Suppl 3:10-5. Review.

Supplemental Content

Support Center